CRVS•benzinga•
Corvus Pharmaceuticals Announces Additional Data From Phase 1/1b Clinical Trial Of Soquelitinib For The Treatment Of Patients With T Cell Lymphoma Is Being Presented At The Annual T-Cell Lymphoma Forum Taking Place March 20-22, 2025
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 20, 2025 by benzinga